PubMed

Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.

Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, Grassi G, Cavallo-Perin P, Bruno G.

Diabetes Care. 2009 Feb;32(2):301-5. Epub 2008 Nov 18.PMID: 19017769 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

[No authors listed]

Diabetes Care. 1999 Jan;22(1):99-111.PMID: 10333910 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.

Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R.

Diabetes Nutr Metab. 2002 Aug;15(4):232-9.PMID: 12416660 [PubMed - indexed for MEDLINE]Related articles

Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.

Shim WS, Kim SK, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS.

Eur J Endocrinol. 2006 Oct;155(4):615-22.PMID: 16990662 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of overweight on chronic microvascular complications in type 1 diabetic patients.

De Block CE, De Leeuw IH, Van Gaal LF.

Diabetes Care. 2005 Jul;28(7):1649-55.PMID: 15983315 [PubMed - indexed for MEDLINE]Related articlesFree article

The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.

Winocour PH, Jeacock J, Kalsi P, Gordon C, Anderson DC.

Diabetes Res Clin Pract. 1990 Apr;9(1):23-35.PMID: 2351037 [PubMed - indexed for MEDLINE]Related articles

Rate of beta-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years.

Nakanishi K, Watanabe C.

J Clin Endocrinol Metab. 2008 Dec;93(12):4759-66. Epub 2008 Sep 30.PMID: 18826998 [PubMed - indexed for MEDLINE]Related articles

Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.

Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW.

Diabetes Care. 2007 Oct;30(10):2523-8. Epub 2007 Jul 13.PMID: 17630266 [PubMed - indexed for MEDLINE]Related articlesFree article

Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.

Diabetes. 2002 Aug;51(8):2629-36.PMID: 12145180 [PubMed - indexed for MEDLINE]Related articlesFree article

Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.

Ebeling P, Koivisto VA.

Acta Diabetol. 1997 Mar;34(1):33-8.PMID: 9134055 [PubMed - indexed for MEDLINE]Related articles

Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G.

Diabetes Care. 1993 Jun;16(6):902-10.PMID: 8325204 [PubMed - indexed for MEDLINE]Related articles

Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.

[No authors listed]

J Hypertens. 1993 Mar;11(3):309-17.PMID: 8387089 [PubMed - indexed for MEDLINE]Related articles

Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.

Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J.

Pediatr Diabetes. 2009 May;10(3):168-76. Epub 2008 Oct 22.PMID: 19175900 [PubMed - indexed for MEDLINE]Related articles

White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.

Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, Chan NN, Chan JC.

Diabetes Care. 2004 Jan;27(1):216-22.PMID: 14693992 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.

[No authors listed]

J Clin Endocrinol Metab. 1987 Jul;65(1):30-6.PMID: 2884229 [PubMed - indexed for MEDLINE]Related articles

The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide.

Haupt E, Benecke A, Haupt A, Herrmann R, Vogel H, Walter C.

Exp Clin Endocrinol Diabetes. 1999;107(7):435-41.PMID: 10595594 [PubMed - indexed for MEDLINE]Related articles

Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.

Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH; EURODIAB IDDM Complications Study.

Diabet Med. 2001 Jan;18(1):59-67.PMID: 11168343 [PubMed - indexed for MEDLINE]Related articles

Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?

Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P.

Diabetes Metab. 2008 Dec;34(6 Pt 1):612-6. Epub 2008 Sep 27.PMID: 18824382 [PubMed - indexed for MEDLINE]Related articles

Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.

Mäkimattila S, Schlenzka A, Mäntysaari M, Bergholm R, Summanen P, Saar P, Erkkilä H, Yki-Järvinen H.

Diabetes Care. 2000 Nov;23(11):1686-93.PMID: 11092293 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article